Inhibition of oxidation of low density lipoprotein by vitamin E and related compounds.
The oxidation of low density lipoprotein (LDL) was carried out aiming specifically at elucidating the anti-oxidant action of alpha-tocopherol. Lipophilic and hydrophilic azo compounds and copper induced the oxidation of LDL similarly to give cholesterol ester and phosphatidylcholine hydroperoxides as major products. The antioxidant potency of alpha-tocopherol in LDL was much poorer than in homogeneous solution. Doxyl stearic acids were used as spin probe and incorporated in LDL. The rate of reduction of doxyl nitroxide in LDL by ascorbate decreased with increasing distance from the LDL surface. From the competition between the spin probe and alpha-tocopherol in scavenging radical, it was found that the efficacy of radical scavenging by alpha-tocopherol became smaller as the radical went deeper into the interior of LDL. On the other hand, 2,2,5,7,8-pentamethyl-6-chromal spared the spin label regardless of the position of nitroxide. The antioxidant activity of chromanols against LDL oxidation increased with decreasing length of isoprenoid side chain at the 2-position. All these results were interpreted by location and low mobility of alpha-tocopherol in LDL. The tocopherol mediated propagation was observed notably at low rate of radical flux, but this was suppressed by reductant such as ascorbic acid and ubiquinol.
Gotoh
N
N
Research Center for Advanced Science and Technology, University of Tokyo, Japan.
Noguchi
N
N
Tsuchiya
J
J
Morita
K
K
Sakai
H
H
Shimasaki
H
H
Niki
E
E
D000578:Amidines / Q000494:pharmacology; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000737:chemistry / Q000494:pharmacology; D001391:Azo Compounds / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D004578:Electron Spin Resonance Spectroscopy; D016166:Free Radical Scavengers / Q000494:pharmacology; D006801:Humans; D008077:Lipoproteins, LDL / Q000187:drug effects* / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology; D010084:Oxidation-Reduction; D012996:Solutions; D013229:Stearic Acids / Q000737:chemistry; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000494:pharmacology; D014810:Vitamin E / Q000031:analogs & derivatives / Q000494:pharmacology*
D000578:Amidines; D000975:Antioxidants; D001391:Azo Compounds; D016166:Free Radical Scavengers; D008077:Lipoproteins, LDL; D009570:Nitriles; D012996:Solutions; D013229:Stearic Acids; C055792:2,2'-azobis(2,4-dimethylvaleronitrile); D014451:Ubiquinone; D014810:Vitamin E; C031183:stearic acid; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; C003741:ubiquinol; D001205:Ascorbic Acid